Last reviewed · How we verify
NCT04119739
Pain Reduction Produced by Different Treatments in Carpal Tunnel Syndrome
Phase 4 trial testing Median nerve neural mobilization in Carpal Tunnel Syndrome in 117 participants. Completed in 28 July 2020.
20 July 2020
Quick facts
| Lead sponsor | Francisco Unda Solano |
|---|---|
| Phase | Phase 4 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | supportive care |
| Enrollment | 117 |
| Start date | 14 April 2020 |
| Primary completion | 20 July 2020 |
| Estimated completion | 28 July 2020 |
| Sites | 1 location across Venezuela |
Drugs / interventions tested
- Median nerve neural mobilization
- Ibuprofen Arginine — full drug profile →
Conditions studied
- Carpal Tunnel Syndrome — all drugs for Carpal Tunnel Syndrome →
Sponsor
Francisco Unda Solano
Who can join
Adults 18 to 70, any sex, with Carpal Tunnel Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Pain reduction effects of the median nerve neural mobilization technique (a physiotherapy treatment) will be compared to those produced by a pharmaceutical treatment and the absence of treatment, in subjects who suffer carpal tunnel syndrome.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04119739
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Median nerve neural mobilization
Trials testing the same drug.
- NCT06781489 — Pain Reduction Caused by the Combined Treatment of Physiotherapy, Oral Gabapentin and Oral Ibuprofen Arginine. · Phase 4 · completed
- NCT04328805 — Ibuprofen and Neural Mobilization Treatment in Carpal Tunnel Syndrome. · Phase 4 · completed
- NCT04329247 — Physical Therapy in the Treatment of Carpal Tunnel Syndrome · NA · completed
- NCT04285281 — Oral Gabapentin and Median Nerve Mobilization in the Treatment of Carpal Tunnel Syndrome · Phase 4 · completed
- NCT04025203 — Pain Reduction and Changes in Upper Limb Function Produced by Different Treatments in Carpal Tunnel Syndrome · Phase 4 · completed
Other recruiting trials for Carpal Tunnel Syndrome
Currently open trials in the same condition.
- NCT07312123 — A Study to See Whether Taking a Mix of Vitamins Can Help Adults Recover Better After Surgery for Carpal Tunnel Syndrome · NA · recruiting
- NCT07334964 — Ultrasound-Guided Carpal Tunnel Infiltration: Comparison Between the Manual Method and a Robot-Assisted Method · NA · recruiting
- NCT07414069 — High-Intensity Laser Therapy in Carpal Tunnel Syndrome: Clinical, Sonographic, and Electrophysiological Outcomes · NA · recruiting
- NCT07114913 — Symptom Distribution and Pain Sensitization in Carpal Tunnel Syndrome · recruiting
- NCT06905769 — Effects of Aquatic Therapy Versus Neuro-dynamic Technique for the Treatment of Carpal Tunnel Syndrome Patient · NA · active not recruiting
Other Francisco Unda Solano trials
Trials by the same sponsor.
- NCT04025203 — Pain Reduction and Changes in Upper Limb Function Produced by Different Treatments in Carpal Tunnel Syndrome · Phase 4 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04119739 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Francisco Unda Solano
- Last refreshed: 10 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04119739.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing